Research led by University of Birmingham scientists in collaboration with Northwestern University in Chicago, US, has provided fresh insight into the role of male hormone in supporting and disrupting the production of eggs ...
Apr 3, 2017
Treatment with the immune checkpoint inhibitor nivolumab (Opdivo) yielded durable responses in some patients with advanced non-small cell lung cancer (NSCLC), with a five-year survival rate of 16 percent, according to data ...
Apr 3, 2017
Digitising health records to include key patient and treatment information could help identify patterns of illness, effectiveness of treatments and how these patients' gender and ethnicity influence this.
Apr 3, 2017
Female and male workers over 50 years old respond in different ways to severe health problems. If physically recovered, men tend to work more hours, but women prefer to enjoy more free time. And single men and women risk ...
Apr 3, 2017
New research shows that the light environment in intensive care affects how patients feel – even a year after completed hospitalization. With light adapted to the time of day, health even improves for patients who are barely ...
Apr 3, 2017
Among patients with metastatic triple-negative breast cancer (TNBC) who were treated with the anti-PD-L1 cancer immunotherapy atezolizumab (Tecentriq), those who responded to the medicine lived significantly longer (overall ...
Apr 3, 2017
The immunotherapeutic avelumab (Bavencio) was well tolerated by patients with advanced Merkel cell carcinoma, and the majority of those whose cancer responded to avelumab treatment had durable responses, according to results ...
Apr 3, 2017
